versus 138 - bejo 138 slot
$800.00
Allocation to sacubitril/valsartan had no significant effect on fatal serious adverse events (1 [0. dana slot 138 5%] versus 1 [0 5%]) or on any nonfatal serious adverse events (61 [29 5%] versus 59 [28 5%]; rate ratio, 1 07; 95% CI, 0 75–1 53; P=0 70) (Table IV in the online-only Data Supplement) One case of angioedema occurred in a participant allocated